Aspiriant LLC’s Mastercard MA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.55M | Sell |
3,107
-360
| -10% | -$190K | 0.04% | 127 |
|
|
2025
Q4 | $1.98M | Buy |
3,467
+327
| +10% | +$183K | 0.06% | 111 |
|
|
2025
Q3 | $1.79M | Sell |
3,140
-186
| -6% | -$107K | 0.05% | 107 |
|
|
2025
Q2 | $1.87M | Buy |
3,326
+219
| +7% | +$121K | 0.06% | 105 |
|
|
2025
Q1 | $1.7M | Buy |
3,107
+62
| +2% | +$33.8K | 0.06% | 105 |
|
|
2024
Q4 | $1.6M | Buy |
3,045
+160
| +6% | +$82.8K | 0.06% | 107 |
|
|
2024
Q3 | $1.42M | Sell |
2,885
-47
| -2% | -$21.9K | 0.05% | 116 |
|
|
2024
Q2 | $1.29M | Sell |
2,932
-536
| -15% | -$244K | 0.05% | 124 |
|
|
2024
Q1 | $1.67M | Sell |
3,468
-77
| -2% | -$35.2K | 0.07% | 108 |
|
|
2023
Q4 | $1.51M | Buy |
3,545
+18
| +0.5% | +$7.23K | 0.07% | 109 |
|
|
2023
Q3 | $1.4M | Buy |
3,527
+126
| +4% | +$50.6K | 0.07% | 110 |
|
|
2023
Q2 | $1.34M | Sell |
3,401
-80
| -2% | -$30K | 0.07% | 107 |
|
|
2023
Q1 | $1.26M | Sell |
3,481
-232
| -6% | -$84.3K | 0.07% | 112 |
|
|
2022
Q4 | $1.29M | Buy |
3,713
+266
| +8% | +$87.6K | 0.07% | 109 |
|
|
2022
Q3 | $980K | Sell |
3,447
-44
| -1% | -$14.6K | 0.05% | 121 |
|
|
2022
Q2 | $1.1M | Buy |
3,491
+104
| +3% | +$35.8K | 0.05% | 112 |
|
|
2022
Q1 | $1.21M | Buy |
3,387
+72
| +2% | +$25.9K | 0.07% | 121 |
|
|
2021
Q4 | $1.19M | Buy |
3,315
+1,450
| +78% | +$501K | 0.06% | 122 |
|
|
2021
Q3 | $649K | Sell |
1,865
-14
| -0.7% | -$5.09K | 0.04% | 146 |
|
|
2021
Q2 | $686K | Sell |
1,879
-403
| -18% | -$150K | 0.04% | 141 |
|
|
2021
Q1 | $811K | Buy |
2,282
+150
| +7% | +$52.3K | 0.05% | 119 |
|
|
2020
Q4 | $759K | Sell |
2,132
-104
| -5% | -$34.6K | 0.05% | 121 |
|
|
2020
Q3 | $756K | Sell |
2,236
-230
| -9% | -$74.8K | 0.06% | 123 |
|
|
2020
Q2 | $730K | Hold |
2,466
| – | – | 0.07% | 108 |
|
|
2020
Q1 | $595K | Sell |
2,466
-1,531
| -38% | -$455K | 0.06% | 112 |
|
|
2019
Q4 | $1.19M | Sell |
3,997
-160
| -4% | -$45.1K | 0.11% | 82 |
|
|
2019
Q3 | $1.13M | Sell |
4,157
-183
| -4% | -$50.4K | 0.1% | 94 |
|
|
2019
Q2 | $1.15M | Sell |
4,340
-76
| -2% | -$19K | 0.1% | 98 |
|
|
2019
Q1 | $1.04M | Sell |
4,416
-103
| -2% | -$22.2K | 0.09% | 108 |
|
|
2018
Q4 | $851K | Sell |
4,519
-445
| -9% | -$88.4K | 0.06% | 113 |
|
|
2018
Q3 | $1.1M | Buy |
4,964
+501
| +11% | +$105K | 0.09% | 102 |
|
|
2018
Q2 | $877K | Buy |
4,463
+1,884
| +73% | +$354K | 0.08% | 115 |
|
|
2018
Q1 | $452K | Buy |
+2,579
| New | +$441K | 0.04% | 159 |
|
|
2017
Q4 | – | Sell |
-3,359
| Closed | -$474K | – | 134 |
|
|
2017
Q3 | $474K | Sell |
3,359
-1,261
| -27% | -$167K | 0.04% | 141 |
|
|
2017
Q2 | $561K | Buy |
4,620
+2,532
| +121% | +$300K | 0.05% | 137 |
|
|
2017
Q1 | $235K | Buy |
+2,088
| New | +$229K | 0.02% | 191 |
|
Other funds holding MA
VCM
VPM
Aspiriant LLC's MA Position: Q1 2026 in Review
Aspiriant LLC reduced its Mastercard (MA) stake by 10% in Q1 2026, selling an estimated $190K and leaving 3,107 shares worth $1.55M. The position accounts for 0.04% of the portfolio, ranked #127.
Aspiriant LLC first reported a position in MA in Q1 2017 and has held it in 36 quarters since. The position peaked at $1.98M in Q4 2025. 3,599 funds tracked by Wall St. Rank hold MA as of Q1 2026.
- Aspiriant LLC held 3,107 shares of Mastercard worth $1.55M as of Q1 2026.
- Aspiriant LLC sold 360 Mastercard shares in Q1 2026, an estimated $190K.
- Mastercard made up 0.04% of Aspiriant LLC's portfolio in Q1 2026, its #127 holding.
- Aspiriant LLC first reported a position in Mastercard in Q1 2017 and has held it in 36 quarters since.
- Aspiriant LLC's Mastercard position peaked at $1.98M in Q4 2025.
- 3,599 funds tracked by Wall St. Rank held Mastercard as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.